Rani Therapeutics IPO

ranitherapeutics.com

Rani Therapeutics is the developer of a platform for the oral delivery of biologic drugs.

Founded2012
Total Funding to Date$116.33MM
Register for Details

For more details on financing and valuation for Rani Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Rani Therapeutics Ticker Symbol

Rani Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Rani Therapeutics Stock Price

The stock price for Rani Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Major Investors for Rani Therapeutics

GV
Bossa Ventures
Cathay Venture
GeneScience Pharmaceuticals
Shire

Other companies like Rani Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM